Pharmacyclics Halted Before Positive Trial News

March 16, 2015 8:12 PM

13 0

Pharmacyclics, the maker of lymphoma and leukemia drug Imbruvica, has just released positive news regarding its latest trial for the drug. Shares of the pharmaceutical company were halted before the release and then ended the trading day up by 0.67% to close at $256.70 per share.

Earlier this month, AbbVie reportedly made an offer of $261.25 per share in cash and stock to acquire Pharmacyclics.

Also read: U.S., Britain Issue Warnings Over Chinese Telecom Equipment Maker ZTE

Read more

To category page